Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 20;17(1):18809.
doi: 10.7448/IAS.17.1.18809. eCollection 2014.

Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review

Elke Wynberg  1 , Graham Cooke  1 , Amir Shroufi  2 , Steven D Reid  1 , Nathan Ford  3
Affiliations

Impact of point-of-care CD4 testing on linkage to HIV care: a systematic review

Elke Wynberg et al. J Int AIDS Soc. .

Abstract

Introduction: Point-of-care testing for CD4 cell count is considered a promising way of reducing the time to eligibility assessment for antiretroviral therapy (ART) and of increasing retention in care prior to treatment initiation. In this review, we assess the available evidence on the patient and programme impact of point-of-care CD4 testing.

Methods: We searched nine databases and two conference sites (up until 26 October 2013) for studies reporting patient and programme outcomes following the introduction of point-of-care CD4 testing. Where appropriate, results were pooled using random-effects methods.

Results: Fifteen studies, mainly from sub-Saharan Africa, were included for review, providing evidence for adults, adolescents, children and pregnant women. Compared to conventional laboratory-based testing, point-of-care CD4 testing increased the likelihood of having CD4 measured [odds ratio (OR) 4.1, 95% CI 3.5-4.9, n=2] and receiving a CD4 result (OR 2.8, 95% CI 1.5-5.6, n=6). Time to being tested was significantly reduced, by a median of nine days; time from CD4 testing to receiving the result was reduced by as much as 17 days. Evidence for increased treatment initiation was mixed.

Discussion: The results of this review suggest that point-of-care CD4 testing can increase retention in care prior to starting treatment and can also reduce time to eligibility assessment, which may result in more eligible patients being initiated on ART.

Keywords: HIV/AIDS; antiretroviral therapy; point-of-care CD4; retention; treatment initiation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study selection process
Figure 2
Figure 2
Pooled odds ratio of achieving the next step in the treatment cascade comparing point of care CD4 testing against standard of care
See this image and copyright information in PMC

References

    1. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, Gsponer T, et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012;(12):1509–20. - PMC - PubMed
    1. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 2011;8(7):e1001056. - PMC - PubMed
    1. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383. - PMC - PubMed
    1. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS. 2012;26(16):2059–67. - PubMed
    1. Murtagh M. UNITAID HIV/AIDS diagnostics technology landscape: semi-annual update. 2nd ed. Geneva: UNITAID; 2011.

Publication types